Edition:
United Kingdom

Hisamitsu Pharmaceutical Co Inc (4530.T)

4530.T on Tokyo Stock Exchange

6,810JPY
12:31am GMT
Change (% chg)

¥-60 (-0.87%)
Prev Close
¥6,870
Open
¥6,800
Day's High
¥6,830
Day's Low
¥6,780
Volume
15,900
Avg. Vol
165,590
52-wk High
¥9,950
52-wk Low
¥5,940

Latest Key Developments (Source: Significant Developments)

Hisamitsu Pharmaceutical Expected To Post 15 PCt Drop In H1 Operating Profit To 11 BLn Yen - Nikkei
Friday, 5 Oct 2018 

Oct 5 (Reuters) - NIKKEI::HISAMITSU PHARMACEUTICAL EXPECTED TO POST 15 PERCENT DROP IN FIRST-HALF OPERATING PROFIT TO 11 BILLION YEN - NIKKEI.HISAMITSU PHARMACEUTICAL'S SALES FOR 6 MONTHS ENDED AUGUST APPEAR TO HAVE FALLEN 5 PERCENT TO ABOUT 70 BILLION YEN- NIKKEI.HISAMITSU PHARMACEUTICAL'S FY OPERATING PROFIT IS FORECAST TO SAG 9 PERCENT TO 24 BILLION YEN AS SALES INCH UP SLIGHTLY TO 148.5 BILLION YEN - NIKKEI.  Full Article

Hisamitsu Pharmaceutical Co's Operating Profit For March-May Qtr Likely Slid 12 Pct - Nikkei
Tuesday, 26 Jun 2018 

June 27 (Reuters) - Hisamitsu Pharmaceutical Co Inc <4530.T>::HISAMITSU PHARMACEUTICAL'S MARCH-MAY QUARTER SALES LIKELY SLIPPED 3% TO ABOUT 35 BILLION YEN - NIKKEI.HISAMITSU PHARMACEUTICAL CO OPERATING PROFIT FOR MARCH-MAY QUARTER LIKELY SLID 12 PERCENT ON YEAR TO ABOUT 4.5 BILLION YEN - NIKKEI .  Full Article

Noven files patent infringement lawsuit against Alvogen
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - ‍Noven Pharmaceuticals :‍Noven Pharmaceuticals says filed lawsuit in a U.S. court against Alvogen and Alvogen pine brook llc for patent infringement.Says Alvogen is seeking approval to market & sell generic version of Minivelle prior to expiration of 2 of Noven's orange book listed patents​.  Full Article

Hisamitsu Pharmaceutical's operating profit probably shrank 3 percent to 12.5 billion yen - Nikkei
Friday, 22 Sep 2017 

Sept 22 (Reuters) - Nikkei::Hisamitsu pharmaceutical's operating profit probably shrank 3 percent to 12.5 billion yen ($111 million) in the March-August period‍​ - Nikkei.Sales of Hisamitsu Pharmaceutical probably fell 1% to about 74 billion yen in the March-August period - Nikkei.Hisamitsu Pharmaceutical Co Inc expected to maintain its guidance for the fiscal year ending February 2018 - Nikkei.  Full Article